HSP-1-specific nanobodies alter chaperone function in vitro and in vivo
Open Access
- 4 February 2026
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (3) , 111238
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Institute of General Medical Sciences (1R35GM142561)
- National Institute on Aging
- A. Alfred Taubman Medical Research Institute
- European Regional Development Fund (2024 FGI 0004)
This publication has 62 references indexed in Scilit:
- Designed peptide binders and nanobodies as PROTAC starting points for targeted degradation of PCNA and BCL6International Journal of Biological Macromolecules, 2025
- Screening and optimization of shark nanobodies against SARS-CoV-2 spike RBDAntiviral Research, 2024
- HSP70-binding motifs function as protein quality control degronsCellular and Molecular Life Sciences, 2023
- Chemical Regulation of the Protein Quality Control E3 Ubiquitin Ligase C‐Terminus of Hsc70 Interacting Protein (CHIP)ChemBioChem, 2022
- Site‐Specific Protein Labeling via Sortase‐Mediated TranspeptidationCurrent Protocols in Protein Science, 2017
- Spatiotemporal Control of Intracellular Phase Transitions Using Light-Activated optoDropletsCell, 2017
- The human HSP70 family of chaperones: where do we stand?Cell Stress and Chaperones, 2016
- Structurally Defined αMHC‐II Nanobody–Drug Conjugates: A Therapeutic and Imaging System for B‐Cell LymphomaAngewandte Chemie International Edition, 2016
- Hsp70 molecular chaperones and Parkinson's diseaseBiopolymers, 2009
- Hsp70 chaperones: Cellular functions and molecular mechanismCellular and Molecular Life Sciences, 2005